SG10201602399SA - Inhibitor for corneal epithelial cell death, inhibitor characterized by combining hyaluronic acid and flavin adenine dinucleotide - Google Patents

Inhibitor for corneal epithelial cell death, inhibitor characterized by combining hyaluronic acid and flavin adenine dinucleotide

Info

Publication number
SG10201602399SA
SG10201602399SA SG10201602399SA SG10201602399SA SG10201602399SA SG 10201602399S A SG10201602399S A SG 10201602399SA SG 10201602399S A SG10201602399S A SG 10201602399SA SG 10201602399S A SG10201602399S A SG 10201602399SA SG 10201602399S A SG10201602399S A SG 10201602399SA
Authority
SG
Singapore
Prior art keywords
inhibitor
hyaluronic acid
cell death
epithelial cell
adenine dinucleotide
Prior art date
Application number
SG10201602399SA
Inventor
Asuka Sakamoto
Masatsugu Nakamura
Original Assignee
Santen Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Santen Pharmaceutical Co Ltd filed Critical Santen Pharmaceutical Co Ltd
Publication of SG10201602399SA publication Critical patent/SG10201602399SA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728Hyaluronic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7084Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
SG10201602399SA 2011-09-27 2012-09-26 Inhibitor for corneal epithelial cell death, inhibitor characterized by combining hyaluronic acid and flavin adenine dinucleotide SG10201602399SA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2011210885 2011-09-27

Publications (1)

Publication Number Publication Date
SG10201602399SA true SG10201602399SA (en) 2016-05-30

Family

ID=47995598

Family Applications (2)

Application Number Title Priority Date Filing Date
SG11201400943RA SG11201400943RA (en) 2011-09-27 2012-09-26 Inhibitor for corneal epithelial cell death, inhibitor characterized by combining hyaluronic acid and flavin adenine dinucleotide
SG10201602399SA SG10201602399SA (en) 2011-09-27 2012-09-26 Inhibitor for corneal epithelial cell death, inhibitor characterized by combining hyaluronic acid and flavin adenine dinucleotide

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG11201400943RA SG11201400943RA (en) 2011-09-27 2012-09-26 Inhibitor for corneal epithelial cell death, inhibitor characterized by combining hyaluronic acid and flavin adenine dinucleotide

Country Status (13)

Country Link
US (1) US20140228425A1 (en)
EP (1) EP2762144B1 (en)
JP (1) JP6063191B2 (en)
KR (1) KR20140068190A (en)
CN (1) CN103826643B (en)
CA (1) CA2850190A1 (en)
EA (1) EA201490700A1 (en)
GE (1) GEP20166431B (en)
HK (1) HK1193349A1 (en)
MY (1) MY166466A (en)
SG (2) SG11201400943RA (en)
TW (1) TWI590827B (en)
WO (1) WO2013047568A1 (en)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2773076B1 (en) * 1997-12-29 2000-05-19 Chauvin Lab Sa USE OF FLAVIN-ADENIN-DINUCLEOTIDE FOR THE PREPARATION OF OPHTHALMIC COMPOSITIONS USEFUL FOR THE TREATMENT OF DRY EYE
JP4324421B2 (en) 2003-07-04 2009-09-02 株式会社中京遊技 Pachinko ball collection device
CA2538760A1 (en) * 2003-09-19 2005-03-31 Otsuka Pharmaceutical Co., Ltd. Human .beta.-defensin secretion promoter
JP5301069B2 (en) 2004-04-15 2013-09-25 ロート製薬株式会社 Azulene-containing aqueous solution
JP4856392B2 (en) 2004-04-23 2012-01-18 ロート製薬株式会社 Preservative and aqueous composition containing the same
JP4999304B2 (en) * 2004-09-27 2012-08-15 ロート製薬株式会社 Mucosal composition containing hyaluronic acid or a salt thereof
EP2057983A1 (en) * 2007-11-07 2009-05-13 Bruschettini S.r.l. Compositions for the topical protection of the ocular tissues from the damaging effects of ultraviolet radiations

Also Published As

Publication number Publication date
TWI590827B (en) 2017-07-11
WO2013047568A1 (en) 2013-04-04
MY166466A (en) 2018-06-27
EP2762144A4 (en) 2015-03-25
TW201318629A (en) 2013-05-16
CN103826643A (en) 2014-05-28
CA2850190A1 (en) 2013-04-04
EA201490700A1 (en) 2016-01-29
GEP20166431B (en) 2016-02-10
HK1193349A1 (en) 2014-09-19
CN103826643B (en) 2016-01-20
KR20140068190A (en) 2014-06-05
EP2762144B1 (en) 2017-04-12
SG11201400943RA (en) 2014-08-28
JP6063191B2 (en) 2017-01-18
JP2013082697A (en) 2013-05-09
US20140228425A1 (en) 2014-08-14
EP2762144A1 (en) 2014-08-06

Similar Documents

Publication Publication Date Title
IL288509A (en) Mammalian cell culture
IL231264A0 (en) Ophthalmic compositions comprising prostaglandin f2 alpha derivatives and hyaluronic acid
IL232450B (en) Methods for differentiating stem cells, cell populations of in vitro differentiated cells and compositions comprising thereof, and uses of such compositions
EP2799537A4 (en) Normalization of culture of corneal endothelial cells
EP2765188A4 (en) Method for producing corneal endothelial cell
EP2733201A4 (en) Method for preparing corneal endothelial cell
PT2788472T (en) Method of directed differentiation producing corneal endothelial cells, compositions thereof, and uses thereof
EP2729561A4 (en) Cell culture process
PL2775842T3 (en) 1-substituted-5-fluoro-3,6-dihydro-6-imino-2(1H)-pyrimidinone derivatives as fungicidal agents for use in plant protection
EP3144319B8 (en) Cell culture composition comprising laminin-521
EP2758419B8 (en) Novel betulinic acid derivatives with antiviral activity
IL227529A0 (en) Compositions and methods for cell transplantation
HK1205757A1 (en) A glycosylated modified flavin adenine dinucleotide dependent glucose dehydrogenase
ZA201400140B (en) Non-ionic associative thickeners containing alkyl,formulations containing them and their uses
EP2678339A4 (en) Methods and compositions for treating -thalassemia and sickle cell disease
EP2696876A4 (en) Aqueous ophthalmic composition
HK1192140A1 (en) Aqueous ophthalmic composition
SG11201500386WA (en) Cell culture of corneal endothelial cells
EP2740790A4 (en) Composition for embryo culture
HK1193349A1 (en) Inhibitor for corneal epithelial cell death, inhibitor characterized by combining hyaluronic acid and flavin adenine dinucleotide
WO2011109113A9 (en) Uses of beta-nicotinamide adenine dinucleotide
SG10201602401PA (en) Corneal epithelial cell death inhibitor containing flavin adenine dinucleotide or salt thereof as active ingredient
EG27087A (en) New technique for differentiation of stem cells using non-ionized
AU2011900404A0 (en) Onestop Vehice Chocks (with Holster)
GB201102831D0 (en) Follicle culture